ASA claims that BevMD used its name and trademarks without permission and made multiple false and misleading statements about the ASA, including false claims that ASA had approved and endorsed BevMD’s Clearfast product.
As a nonprofit association, the society does not test, endorse or approve medical products, said ASA CEO Paul Pomerantz.
The suit has been filed in the United States District Court for the Northern District of Illinois, Eastern Division.
More articles on anesthesia:
University of Florida College of Medicine names Dr. Timothy Morey chair
MEDNAX acquires MEMAC Associates
Dr. Jean-François Pittet to serve as next editor-in-chief of Anesthesia & Analgesia
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.